EUVIMEDEUVIMED entdecken
Crossref

Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis

Xiaoqiong Li, Yunruo Xu, Luming Xu, Qilin Li, Yiwei Zhao, Chunyu Wei, Yuyu Li, Lin Wang iD, Zheng Wang iD

ACS Applied Materials & Interfaces · 20.05.2026 · 18 (19) · 27395-27411

DOI: 10.1021/acsami.6c06670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 04.05.2026. Verfasst von Xiaoqiong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Regenerative Medicine and Multi-disciplinary Translational Research, Huazhong University of Science and Technology, Wuhan 430…. Hauptthemen laut MEDLINE: Meloxicam, Hydrogels, Tryptophan, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Major Scientific and Technological Innovation Projects of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeloxicamHydrogelsTryptophanNeoplasm Recurrence, LocalImmunomodulating AgentsAnimalsFemaleTumor MicroenvironmentHumansMiceCell Line, TumorNeoplasm Metastasis

Stichwörter der Autor:innen

hydrogelimmunotherapymetastasisrelapsetumor

Substanzen

MeloxicamHydrogelsTryptophan1-methyltryptophanImmunomodulating Agents

Autor:innen und Institutionen

  • Hubei Key Laboratory of Regenerative Medicine and Multi-disciplinary Translational Research, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Provincial Engineering Research Center of Clinical Laboratory and Active Health Smart Equipment, Wuhan 430022, China.
  • Hubei Clinical Research Center of Minimally Invasive Surgery, Wuhan 430022, China.
  • Key Laboratory of Biological Targeted Therapy, Ministry of Education, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • The Department of Laboratory Medicine at Wuhan No. 4 Hospital, Wuhan 430033, China.

ORCID-Profile: Lin Wang, Zheng Wang

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Major Scientific and Technological Innovation Projects of Hubei Province
  • Wuhan Natural Science Foundation Exploration Program
  • Huazhong University of Science and Technology Interdisciplinary Research Support Program
  • Major Scientific and Technological Innovation Projects of Wuhan

Zitieren

APA

Li, X., Xu, Y., Xu, L., Li, Q., Zhao, Y., Wei, C., Li, Y., Wang, L., & Wang, Z. (2026). Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis. ACS Applied Materials & Interfaces, 18(19), 27395-27411. https://doi.org/10.1021/acsami.6c06670

Vancouver

Li X, Xu Y, Xu L, Li Q, Zhao Y, Wei C, et al. Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis. ACS Applied Materials & Interfaces. 2026;18(19):27395-27411. doi:10.1021/acsami.6c06670

BibTeX
@article{Li2026,
  author = {Li, Xiaoqiong and Xu, Yunruo and Xu, Luming and Li, Qilin and Zhao, Yiwei and Wei, Chunyu and Li, Yuyu and Wang, Lin and Wang, Zheng},
  title = {Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {19},
  pages = {27395--27411},
  doi = {10.1021/acsami.6c06670}
}
Kostenlos starten →